Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer.
HCMV
Pentamer
Trimer
antiviral therapy
broadly neutralizing antibody
cryogenic electron microscopy
epitope map
neutralizaton mechanisms
single B cell
Journal
Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918
Informations de publication
Date de publication:
14 Nov 2023
14 Nov 2023
Historique:
received:
23
03
2023
revised:
02
07
2023
accepted:
18
10
2023
medline:
4
12
2023
pubmed:
16
11
2023
entrez:
15
11
2023
Statut:
ppublish
Résumé
Human cytomegalovirus (HCMV) can cause severe diseases in fetuses, newborns, and immunocompromised individuals. Currently, no vaccines are approved, and treatment options are limited. Here, we analyzed the human B cell response of four HCMV top neutralizers from a cohort of 9,000 individuals. By single-cell analyses of memory B cells targeting the pentameric and trimeric HCMV surface complexes, we identified vulnerable sites on the shared gH/gL subunits as well as complex-specific subunits UL
Identifiants
pubmed: 37967532
pii: S1074-7613(23)00449-1
doi: 10.1016/j.immuni.2023.10.009
pii:
doi:
Substances chimiques
Viral Envelope Proteins
0
Membrane Glycoproteins
0
Antibodies, Neutralizing
0
Antibodies, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2602-2620.e10Subventions
Organisme : NIAID NIH HHS
ID : R01 AI097274
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests A patent application encompassing aspects of this work has been filed by the University of Cologne, the University of Ulm, and the University of Duisburg-Essen, listing F.K., C. Sinzger, A.K., M.Z., and M.A. as inventors.